Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.
about
Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary diseasePharmacological interventions for the treatment of anxiety and panic in chronic obstructive pulmonary diseaseAntidepressants for depression in physically ill peopleAntidepressants versus placebo for depression in primary careBenzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adultsResearch advances in geriatric depressionStrategies to improve anxiety and depression in patients with COPD: a mental health perspectiveManaging dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guidelineThe role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study.Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional studyAnxiety and depression in COPD: current understanding, unanswered questions, and research needsAnxiety, depression and disability across the lifespan.Treating depression in patients with chronic disease: recognition and treatment are crucial; depression worsens the course of a chronic illness.The use of psychotropics in the medically ill.Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease.Integrated management strategies for chronic obstructive pulmonary disease.Anxiety and depression-Important psychological comorbidities of COPD.Mood disorders and chronic obstructive pulmonary disease: current research and future needs.Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δDepression in late lifeEpidemiology and treatment of depression in patients with chronic medical illness.Can early introduction of specialized palliative care limit intensive care, emergency and hospital admissions in patients with severe and very severe COPD? a randomized study.Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review.Depression and health status in elderly patients with heart failure: a 6-month prospective study in primary care.Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomesDepression and COPD in older people: a review and discussion.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceCurrent perspectives on management of co-morbid depression in COPD.Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.End of life care in chronic obstructive pulmonary disease: in search of a good death.Developing an intervention for depressed, chronically medically ill elders: a model from COPD.Depression in COPD--management and quality of life considerationsModeling the impact of COPD on the brain.Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.Multidisciplinary care of the patient with chronic obstructive pulmonary disease.Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.Exacerbation rate, health status and mortality in COPD--a review of potential interventionsDepression and health-related quality of life in chronic obstructive pulmonary disease.
P2860
Q24235161-7909FAD8-FA20-4088-819F-116B851DFDDCQ24236047-F836B265-D7B7-470B-BFA9-316C9A9A9AF9Q24236616-0B1228D5-7687-4D8D-B60C-0C1237CD4635Q24239979-654CF4F2-D399-4677-AA0B-C8BE868899FFQ24240945-274328F9-030C-42FD-ADCE-5F37FCE5AB40Q24642269-4FA0F8ED-3A8F-46A3-901E-73FAF8CEED2DQ26765315-BB039A37-F4AD-4775-986A-BE67876BB9B1Q30401937-B3D66C04-CABA-48CF-ABBA-9D67C16BCE0EQ33605177-BEBC9CBA-E94C-442B-BA3A-7EAB0BDF22E5Q33763935-93EE6CE2-3061-4D8A-9B2F-77009F43EB62Q33769925-83DBBAD6-BF4E-464E-BA3B-17C40D99E1A1Q33889881-FCE2802E-7AA9-4E47-8C72-5D0B05FBC08CQ34100447-AFB2C9AC-1877-420A-A079-38D7B686911AQ34108425-B4C4A637-8A5C-449D-AB05-ADF2B52D3827Q34318082-C7596A44-F0BE-4EC0-9A57-3BE177A10EDDQ34418124-9BBACF46-5EF6-492B-BB46-CC0EE9DAEAA4Q34628577-77EC943C-AA0F-4EEC-8A08-34222B68ED3AQ34633241-AB6D8989-714D-4CB1-BD9C-3B5D2900D584Q34747376-98E34FF3-D5FE-4B1D-ABDA-7FA8A169575DQ34868133-EA69D02D-6F6C-4519-9849-E9691F8F6465Q35236164-733BE382-EDEF-44F4-80BE-3702618C3E64Q35237231-FE8A74A2-069A-4DDF-92F0-64A15A985BCBQ35619015-6F992742-6909-4DE9-8FB1-F9B43896137BQ35676138-D31CA686-42B7-4305-85F6-6D3DC24D7603Q35886401-E33C8B24-73F7-4EF4-9A2A-8CA1C234F5FEQ35890594-5052FE26-8DBF-4764-AB77-34DF1BADD9F8Q35910490-4F94A377-8279-45C0-9156-E699D423AC0EQ36063222-9F4C329D-B3C9-4EB4-9ED4-60F098B92288Q36067334-24C7EE13-8E04-498F-A895-A23C50B07C5AQ36669469-D0F2C169-525B-4901-9986-255AC04F6D16Q36849943-318E1C8B-7C5A-4CA9-9518-CED5E336F874Q36859399-D7C2B645-1605-4FD5-9895-4C3598FF2A0FQ36969280-FACBF988-A039-4CE9-B595-1CD63C6AD8B3Q37018840-BDA8EAE8-1F44-47A7-93DC-E7315F61C988Q37070352-56788DB3-B8F7-437C-AC5E-7F5912927E4DQ37094676-8C64E9E8-BFCB-4F8A-A3AA-6743E692E95BQ37103728-0A365097-7A23-4965-BD55-6545CCD0E6D3Q37230812-F8AA9E5E-3701-46BE-A32E-67B8DF6A8A85Q37236165-3F7A5BC2-509B-4653-8B2B-02EC51999CDEQ37298668-B8AC4FEE-9EFB-44FF-9D19-2D9890AE4137
P2860
Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Improvement in mood, physical ...... obstructive pulmonary disease.
@en
Improvement in mood, physical ...... obstructive pulmonary disease.
@nl
type
label
Improvement in mood, physical ...... obstructive pulmonary disease.
@en
Improvement in mood, physical ...... obstructive pulmonary disease.
@nl
prefLabel
Improvement in mood, physical ...... obstructive pulmonary disease.
@en
Improvement in mood, physical ...... obstructive pulmonary disease.
@nl
P2093
P1433
P1476
Improvement in mood, physical ...... obstructive pulmonary disease.
@en
P2093
Deffebach M
Lakshminarayan S
McDonald GJ
VanTuinen C
P304
P356
10.1016/S0033-3182(92)71995-1
P577
1992-01-01T00:00:00Z